Finally, the comparative analysis of the ASXL1 mutation and RAD21 methylation data in our cohort of AML patients revealed similar frequencies of methylation between ASXL1 mutated and ASXL1 wild-type samples (23.3% and 26.7%, respectively). The gene discussed is ASXL1; the disease is acute myeloid leukemia.